Theragen Etex Co.Ltd (066700) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Based on the latest financial reports, Theragen Etex Co.Ltd (066700) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.35 Billion ≈ $2.27 Million USD) by net assets (₩145.00 Billion ≈ $98.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Theragen Etex Co.Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Theragen Etex Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Theragen Etex Co.Ltd total liabilities for a breakdown of total debt and financial obligations.

Theragen Etex Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theragen Etex Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
GCL Global Holdings Ltd Ordinary Shares NASDAQ:GCL	-0.003x
IG Group Holdings PLC LSE:IGG	0.144x
Highlight Communications AG XETRA:HLG	0.373x
Daelim B&Co KO:005750	0.063x
Minda Global Bhd KLSE:5166	0.012x
JAG Bhd KLSE:0024	0.058x
Herige SA PA:ALHRG	0.119x
Ama Marine Public Company Limited BK:AMA	0.058x

Annual Cash Flow Conversion Efficiency for Theragen Etex Co.Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Theragen Etex Co.Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see 066700 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩130.54 Billion ≈ $88.47 Million	₩1.79 Billion ≈ $1.21 Million	0.014x	-82.72%
2023-12-31	₩152.93 Billion ≈ $103.64 Million	₩12.12 Billion ≈ $8.22 Million	0.079x	+18.67%
2022-12-31	₩143.60 Billion ≈ $97.31 Million	₩9.59 Billion ≈ $6.50 Million	0.067x	+271.32%
2021-12-31	₩222.70 Billion ≈ $150.92 Million	₩4.01 Billion ≈ $2.72 Million	0.018x	-49.11%
2020-12-31	₩374.12 Billion ≈ $253.54 Million	₩13.23 Billion ≈ $8.96 Million	0.035x	+12645.45%
2019-12-31	₩135.86 Billion ≈ $92.07 Million	₩37.69 Million ≈ $25.54K	0.000x	+100.12%
2018-12-31	₩80.92 Billion ≈ $54.84 Million	₩-18.58 Billion ≈ $-12.59 Million	-0.230x	-1223.09%
2017-12-31	₩86.93 Billion ≈ $58.91 Million	₩1.78 Billion ≈ $1.20 Million	0.020x	+117.59%
2016-12-31	₩72.10 Billion ≈ $48.86 Million	₩-8.38 Billion ≈ $-5.68 Million	-0.116x	-1825.75%
2015-12-31	₩68.82 Billion ≈ $46.64 Million	₩-415.37 Million ≈ $-281.49K	-0.006x	-1338.61%
2014-12-31	₩82.00 Billion ≈ $55.57 Million	₩39.95 Million ≈ $27.08K	0.000x	-99.59%
2008-12-31	₩26.20 Billion ≈ $17.76 Million	₩3.14 Billion ≈ $2.13 Million	0.120x	--

About Theragen Etex Co.Ltd

KQ:066700 Korea Pharmaceuticals

Market Cap

$62.68 Million

₩92.49 Billion KRW

Market Cap Rank

#21005 Global

#1304 in Korea

Share Price

₩3035.00

Change (1 day)

-0.16%

52-Week Range

₩2460.00 - ₩3315.00

All Time High

₩21800.00